Skip to main content
TipRanks
Go Ultimate75% OFF

Ascendis Pharma (ASND) Q4 2024 Earnings Report

791 Followers

ASND Q4 2024 EPS Results

Actual EPS
-$0.70
Consensus EPS
-$1.08
Beat/Miss
Beat by +$0.38
One Year Ago EPS
-$1.69

ASND Q4 2024 Revenue Results

Actual Revenue
$185.51M
Expected Revenue
$131.60M
Beat/Miss
Beat by +$53.91M
YoY Revenue Growth
+25.30%

Earnings Announcement Details

Quarter
Q4 2024
Date
02/12/2025
Time
After Close
Conference Call
Wednesday, February 12, 2025
ASND Upcoming Earnings

Ascendis Pharma's next earnings date is estimated for February 17, 2027, based on past reporting schedules.

Q4 2024 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

ASND Earnings History

ASND earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 17, 20272026 (Q4)1.78--0.6――
Nov 12, 20262026 (Q3)0.871.19-1.1208.00% (+2.29)
Aug 13, 20262026 (Q2)1.653.11-0.9445.12% (+4.01)
May 07, 20262026 (Q1)―10.72-1.74717.09% (+12.46)
Feb 11, 20262025 (Q4)-0.09-0.60-0.714.06% (+0.10)
Nov 12, 20252025 (Q3)-0.27-1.10-1.8941.86% (+0.79)
Aug 07, 20252025 (Q2)-1.41-0.90-2.157.07% (+1.20)
May 01, 20252025 (Q1)-1.61-1.74-2.5331.30% (+0.79)
Feb 12, 20252024 (Q4)-1.08-0.70-1.6958.44% (+0.99)
Nov 14, 20242024 (Q3)-1.72-1.89-2.9636.06% (+1.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed